Latest AI and machine learning research in dementia for healthcare professionals.
Tau protein aggregates exhibit distinct conformations across tauopathies, but their disease-specific protein interactions remain poorly understood. Here, we demonstrate that disease-specific tau conformations determine unique protein interaction landscapes across Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), and dementia with Lewy bodies (DLB). Through comprehensive interactome p...
Gaining insight into the spectral and temporal alterations in brain connectivity associated with Alzheimer’s disease (AD) may offer pathways toward more informative biomarkers and a deeper understanding of disease mechanisms. We propose FINE (Frequency-aware Interpretable Neural Encoder), a novel deep learning model designed to capture multi-scale temporal and frequency-specific patterns in dynami...
Alzheimer’s disease and related dementias (ADRD) involve overlapping neurodegenerative and vascular pathologies—such as amyloid-β (Aβ), tau, cerebral ...
Alzheimer’s disease (AD) is a progressive and debilitating neurodegenerative disease of the central nervous system, characterized by deterioration in ...
Aberrant biomolecular condensates are implicated in multiple incurable neurological disorders, including Amyotrophic Lateral Sclerosis, Frontotemporal...
The brain’s connectome provides a powerful blueprint for designing efficient neural networks, yet the impact of incorporating its intricate, non-rando...
Alzheimer’s disease (AD) is a major global health concern, expected to affect 12.7 million Americans by 2050. Machine learning (ML) algorithms have be...
Single-omics approaches often provide a limited perspective on complex biological systems, whereas multi-omics integration enables a more comprehensiv...
Alterations in metabolism, stress response, sleep, circadian rhythms, and neuroendocrine processes are key features of aging and neurodegeneration. Th...
Predicting symptom onset in genetic frontotemporal dementia (FTD) is crucial for advancing targeted interventions and clinical trial design. Brain cha...
Olfactory dysfunction is a frequent yet understudied feature of neurodegenerative spectrum disorders, including Alzheimer’s disease (AD) and Parkinson...
The COVID-19 pandemic has intensified concerns about its long-term neurological impact, with growing evidence linking SARS-CoV-2 infection to neurodeg...
Spatial transcriptomics (ST) is a powerful tool for studying the molecular basis of brain diseases. However, most current analyses focus only on nucle...
Digital language markers show promise in detecting early cognitive impairment related to Alzheimer’s disease (AD), yet their relationship with cerebro...
Hyaluronan and proteoglycan link protein 2 (HAPLN2) / Brain link protein-1 (Bral1) is important for the binding of chondroitin sulfate proteoglycans (...
Both genotype and imaging data carry entangled information about the phenotypes. Associations between genotypes and phenotypes can be manifested or ab...
Plasma proteomics captures a functional snapshot of human physiology; yet, most machine learning models treat protein abundances as independent variab...
Single-cell RNA sequencing (scRNA-seq) has significantly advanced our understanding of Alzheimer’s disease and aging by revealing cellular heterogenei...
Proteostasis dysfunction is a hallmark of frontotemporal dementia (FTD) and Alzheimer’s disease (AD), yet the genetic and molecular pathways that disr...
Alzheimer’s disease (AD) is characterized by progressive cognitive decline and increased seizure susceptibility; yet both the mechanistic and temporal...